This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Pierre Fabre Medicament. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Philippe Schambel: Innovator in Anticancer Research
Introduction
Philippe Schambel is a notable inventor based in Castres, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer agents. His work focuses on innovative compounds that have the potential to improve cancer treatment.
Latest Patents
Philippe Schambel holds a patent for "Pyrazolopyridine derivatives as anticancer agent." This invention concerns compounds of a specific general formula and their pharmaceutically acceptable salts. The patent outlines the method of preparation and the uses of these compounds, notably as anticancer agents.
Career Highlights
Throughout his career, Philippe has worked with prominent companies in the pharmaceutical industry, including Pierre Fabre Medicament and Pierre Fabre Médicament. His experience in these organizations has allowed him to contribute to the development of innovative medical solutions.
Collaborations
Philippe has collaborated with talented professionals in his field, including Karim Bedjeguelal and Rémi Rabot. These partnerships have enhanced his research and development efforts, leading to advancements in anticancer therapies.
Conclusion
Philippe Schambel's work in developing pyrazolopyridine derivatives showcases his commitment to advancing cancer treatment. His innovative approach and collaborations highlight the importance of teamwork in scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile